We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global AI-Enabled Medical Imaging Solutions Market Driven by Need for Early Disease Detection

By HospiMedica International staff writers
Posted on 25 May 2023

The AI-enabled medical imaging solutions market is currently in its developmental stages, following the significant role of AI-based tools in combating the COVID-19 pandemic. More...

The pandemic saw an upswing in the adoption of AI in clinical environments due to its various benefits in diagnosing, evaluating prognosis, predicting pandemics, and discovering drugs for COVID-19. COVID-19 had a positive impact on the use of AI in clinical settings and decision-making.

The global AI-enabled medical imaging solutions market is projected to grow at a CAGR of 25.76% from USD 1.85 billion in 2022 to USD 18.36 billion in 2032. The market growth will be driven by increased awareness of early chronic disease detection, improved clinical decisions and accuracy facilitated by AI, a shortage of healthcare workers, technological progress in AI-enabled products and their growing regulatory approvals, and an increase in the therapeutic applications of AI-enabled devices. These are the latest findings of Research and Markets (Dublin, Ireland), a market research firm.

Key opportunities in the global AI-enabled medical imaging solutions market include the adoption of AI-enabled medical imaging solutions in emerging nations, technological improvements in imaging devices, and the integration of AI and deep learning in imaging systems. The market is also expected to see an uptick in collaborations among players, the use of machine learning and deep learning in medical imaging, a variety of new product introductions, and companies expanding into the global AI-enabled medical imaging solutions market.

Based on modality, the AI-enabled medical imaging solutions market is expected to be dominated by the computed tomography (CT) segment. By product, the software segment is likely to dominate the market. Based on deployment model, the cloud- and web-based solutions segment is expected to dominate the market. On the basis of workflow, the AI-enabled medical imaging solutions market is expected to be dominated by the image analysis segment. By therapeutic application, the specialty imaging segment is likely to dominate the market. Geographically, North America will dominate the global AI-enabled medical imaging solutions market.

Related Links:
Research and Markets 


Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hypodermic Syringe
SurTract™ Safety Syringe
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.